The National Times - AI chatbots give bad health advice, research finds

AI chatbots give bad health advice, research finds


AI chatbots give bad health advice, research finds
AI chatbots give bad health advice, research finds / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

Next time you're considering consulting Dr ChatGPT, perhaps think again.

Change text size:

Despite now being able to ace most medical licensing exams, artificial intelligence chatbots do not give humans better health advice than they can find using more traditional methods, according to a study published on Monday.

"Despite all the hype, AI just isn't ready to take on the role of the physician," study co-author Rebecca Payne from Oxford University said.

"Patients need to be aware that asking a large language model about their symptoms can be dangerous, giving wrong diagnoses and failing to recognise when urgent help is needed," she added in a statement.

The British-led team of researchers wanted to find out how successful humans are when they use chatbots to identify their health problems and whether they require seeing a doctor or going to hospital.

The team presented nearly 1,300 UK-based participants with 10 different scenarios, such as a headache after a night out drinking, a new mother feeling exhausted or what having gallstones feels like.

Then the researchers randomly assigned the participants one of three chatbots: OpenAI's GPT-4o, Meta's Llama 3 or Command R+. There was also a control group that used internet search engines.

People using the AI chatbots were only able to identify their health problem around a third of the time, while only around 45 percent figured out the right course of action.

This was no better than the control group, according to the study, published in the Nature Medicine journal.

- Communication breakdown -

The researchers pointed out the disparity between these disappointing results and how AI chatbots score extremely highly on medical benchmarks and exams, blaming the gap on a communication breakdown.

Unlike the simulated patient interactions often used to test AI, the real humans often did not give the chatbots all the relevant information.

And sometimes the humans struggled to interpret the options offered by the chatbot, or misunderstood or simply ignored its advice.

One out of every six US adults ask AI chatbots about health information at least once a month, the researchers said, with that number expected to increase as more people adopt the new technology.

"This is a very important study as it highlights the real medical risks posed to the public by chatbots," David Shaw, a bioethicist at Maastricht University in the Netherlands who was not involved in the research, told AFP.

He advised people to only trust medical information from reliable sources, such as the UK's National Health Service.

W.Baxter--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: